A randomized placebo-controlled trial assessing sphenopalatine ganglion block in endoscopic sinus surgery

Int Forum Allergy Rhinol. 2021 Sep;11(9):1384-1386. doi: 10.1002/alr.22804. Epub 2021 May 19.

Authors

Martin Morisse¹, Bénédicte Rysman¹, Claire Szymanski¹, Rémi Fackeure², François Mouawad¹, Geoffrey Mortuaire^{1

3}

Affiliations

¹ Otorhinolaryngology-Head and Neck Department, Huriez Hospital, Centre Hospitalier Universitaire (CHU) Lille, Lille, France.
² Department of Anesthesiology, Huriez Hospital, CHU Lille, Lille, France.
³ University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.

PMID: 34013619
DOI: 10.1002/alr.22804

No abstract available

Keywords: endoscopic surgery; opioid; pain; ropivacaine; sphenopalatine ganglion blocking.

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Anesthetics, Local
Endoscopy
Humans
Pain, Postoperative
Sphenopalatine Ganglion Block*
Treatment Outcome

Substances

Anesthetics, Local

Associated data

ClinicalTrials.gov/NCT02821169